| [1] |
JIANG Daoli, CHOU Xiaohua, LIU Zhidong, LI Wei, ZHANG Bo, XU Sang, TAN Defei, FANG Yi, LV Dongmei, WANG Tao.
Real-world study of ceftazidime-avibactam in the treatment of multidrug-resistant gram-negative bacterial infections
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1008-1017.
|
| [2] |
WANG Fei, HANG Yongfu, WANG Wei.
Influence of argumented renal clearance on teicoplannin serum concentrations in critical ill patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1043-1048.
|
| [3] |
CHEN Keyu, HUANG Yuan, WANG Xiaojia, ZHENG Yabing.
Clinical application and research progress of antibody drugs conjugation in breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 898-909.
|
| [4] |
CHEN Qun, ZHU Heping, YUAN Xiaolong.
Analysis of 197 cases of pentoxifylline injection and exploring supervision mode of rational drug use in hospitals
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 948-953.
|
| [5] |
LIU Min, KONG Xiang, ZHANG Ye, GU Yifei, XIANG Xuemei, HE Qing, HUANG Kai.
Analysis of reasons for screening failure of healthy subjects in clinical trials of orally inhaled drug products
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 758-766.
|
| [6] |
HOU Qiong, LIU Fei, CHEN Chuanrong.
Immunotherapy combined with anti-angiogenic drugs and chemotherapy in negative driver gene and advanced non-small cell lung cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 775-779.
|
| [7] |
WANG Lin, YU Jianguo, LI Xiao, LUAN Jiajie.
Establish and implement a pre-prescription system for outpatient based on Six Sigma DMAIC model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 780-787.
|
| [8] |
YU Qiaoling, ZHAI Weiwei, LIU Ping, QIU Bo, WU Huizhen.
Research progress in plasma concentration monitoring of rivaroxaban
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 809-817.
|
| [9] |
WANG Juan, LIU Weiying, YE Yucai, FU Wenli, ZHANG Sha, LI Leping.
Research progress of norepinephrine reuptake inhibitor combined with antimuscarinic in the treatment of obstructive sleep apnea
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 714-720.
|
| [10] |
HE Xueru, LI Ying, MA Yinling, FU Yuhao, XUN Xuejiao, DONG Zhanjun.
Pharmacokinetic interaction study between sorafenib and dapagliflozin in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 498-507.
|
| [11] |
DANG Zilong, LIU Haiyang, ZHANG Yangfan, LIU Jinfeng, ZHANG Tianwei, LI Bin, GUO Hong, CHENG Wenyuan, XU Xiaohui, LI Yile, WEI Yuhui, WU Xin'an.
Optimization strategy of antibiotic dosing regimen in intensive care unit patients with augmented renal clearance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 561-571.
|
| [12] |
LIU Tong, XU Jiaming, WANG Jinhuo, YIN Lei, CHEN Yongquan, GUO Jianrong.
Changes of anesthetic drug concentration in plasma during isolation of autologous blood with acute isovolumic hemodilution and its influence on anesthetic effect after reinfusion
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 413-418.
|
| [13] |
ZHANG Mingkang, MA Yanrong, JIN Yongwen, ZHOU Yan, CUI Ruirui, WU Xin'an.
Advances in clinical research on drug-induced acute interstitial nephritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 419-428.
|
| [14] |
LI Ruoning, GUO Zhanli, WANG Yuan, SUN Jianjun.
Platelet-endothelial aggregation receptor 1 and its mediated signalling pathway Advances in the study of the role of platelets and endothelial cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 438-444.
|
| [15] |
MA Guangli, ZHANG Jing.
Application of quantitative pharmacology in vaccine research and de-velopment: overview and prospect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 315-322.
|
